ResearchCharacteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
ResearchReduced Health-Related Quality of Life in Patients With Systemic Sclerosis: A Cross-Sectional Analysis of PROMIS Global Health Data From the International COVAD-2 e-Survey
ResearchRecruitment rate comparison between a virtual tele-research cohort and a traditional centre-based cohort in idiopathic inflammatory myopathy
ResearchFlares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
ResearchCOVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study
ResearchFlares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
ResearchLong-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study
ResearchVaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
ResearchFlares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys
ResearchFlares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study
ResearchEfficacy of Repository-Corticotropin Injection (Acthar) in Refractory Juvenile Dermatomyositis: A Case Series
ResearchCoronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation